Additionally, promising treatments for DM1 have been proposed, which might be able to suppress or eliminate its associated molecular effects, including MBNL1 (Muscleblind Like Splicing Regulator 1) expression enhancers, and toxic RNA degradation [18]. The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.